Perioperative Treatment of Parkinsonian Patients With Parenteral Amantadine
Status:
Terminated
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether administrating of Amantadine (a dopamine
agonist) to patients suffering from Parkinson disease during the perioperative period is
safe, and to asses potential benefits of this treatment.